Sermorelin
Sermorelin is a synthetic peptide analog of growth hormone-releasing hormone (GHRH), also known as growth hormone-releasing factor (GRF). It consists of the first 29 amino acids of the naturally occurring GHRH molecule, which normally contains 44 amino acids. These first 29 amino acids represent the biologically active portion of the hormone, making sermorelin fully functional despite being shorter than the natural version.
Ipamorelin
Ipamorelin is a synthetic pentapeptide (consisting of five amino acids) that functions as a selective growth hormone secretagogue. It was developed in the late 1990s as part of research into compounds that could stimulate growth hormone release in a more targeted and controlled manner than earlier alternatives.
CJC-1295
CJC-1295 is a synthetic peptide analog of growth hormone-releasing hormone, consisting of 30 amino acids, with strategic modifications designed to enhance stability and prolong biological activity. It was originally developed by ConjuChem, a Canadian biotechnology company, in the mid-2000s
Muscle Gain
Tesamorelin
Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH) that is FDA-approved for reducing excess abdominal fat in HIV-infected patients with lipodystrophy. It is a synthetic peptide consisting of all 44 amino acids of human GHRH, with the addition of a trans-3-hexenoic acid group. The N-terminal portion of the molecule has been modified to improve its stability and pharmacokinetics compared with native GHRH.